Hikma Pharmaceuticals is an API and finished-dose manufacturer based in Jordan. It holds one valid CEP across a filed portfolio of 8 molecules. Its filings concentrate with DPM (TN), SFDA (Saudi Arabia) and ANPP (DZ).
| Site | FDA FEI |
|---|---|
| Amman, United Arab Emirates | Not on file |
| Amman, United Arab Emirates | Not on file |
| Amman, Jordan | Not on file |
| Amman, Jordan | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Zoledronic Acid | EDQM, SFDA (Saudi Arabia) | 2 |
| Dasatinib | SFDA (Saudi Arabia) | 1 |
| Erlotinib | SFDA (Saudi Arabia) | 1 |
| Glycopyrronium | SFDA (Saudi Arabia) | 1 |
| Ibrutinib | SFDA (Saudi Arabia) | 1 |
| Neratinib | SFDA (Saudi Arabia) | 1 |
| Ruxolitinib | SFDA (Saudi Arabia) | 1 |
| Sunitinib L-Malate | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| DPM (TN) | 68 | None |
| SFDA (Saudi Arabia) | 35 | None |
| ANPP (DZ) | 5 | None |
Choose your molecules and target markets. Hikma Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free